Collas Crill advised in a private equity deal for Asclepios Bioresearch and in particular assisted with the funding and security structure of the deal.

Asclepios Bioresearch (UK) Limited provided £20,000,000 of funding to develop B-hydroxybutyrate on behalf of Iceland Foods Limited.

The deal is considered an important milestone in the fight against Alzheimer's Disease. Asclepios Bioresearch's scientific committee is particularly excited about the patent's potential against such a debilitating ailment. The testing process is now proceeding and Asclepios Bioresearch's contract research organisation is in active discussions with a pharmaceutical company, who are formulating B-hydroxybutyrate for patient administration.

Also involved in the transaction were Hoiberg A/S (Copenhagen), Jeffery Green Russell (London), Crestgrove Limited, Grant Thornton UK LLP and SWG Services Limited.

Acted for Optimus Capital LLP to establish the Optimus PCC Limited and launch the first cell thereof, the Optimus Opportunities Fund, as an Authorised Closed Ended Fund. The transaction also involved the establishment and structuring of a Guernsey licensed investment manager.  The strategy involved adapting a corporate PCC structure to provide investors with the ability to make private equity style commitments more commonly seen using limited partnerships.

Acted with Louvre Fund Management on the establishment of GoldenPeaks Active Global Fund Limited, a Shariah compliant open-ended Class B collective investment scheme. The fund will invest principally by way of large holdings in Shariah compliant public companies listed in Asia, Western Europe and the United Kingdom. It  is similar in many respects to a previous GoldenPeaks fund on which Collas Crill advised, but is structured to allow participation by those seeking to invest in accordance with Shariah principles. The fund was advised by Amanie Islamic Finance Consultancy and Education LLC of Dubai on issues relating to Shariah principles. This is the third GoldenPeaks fund the firm has worked on.

Instructed by the above to advise in respect of establishing a private equity structure to be managed by the client.  Advised that a conversion of an existing Guernsey non-cellular company to an incorporated cell company would establish the best structure to handle client needs and attended to the conversion process, providing bespoke private equity incorporated cell constitutional documents.

Advised in relation to the establishment of a US$5million+ closed ended public limited liability company regulated as an Expert Fund for investing in the film industry. Our team was led by Adrian Odell, whose specific expertise was gained working in the media team, specialising in the television and film production industry, at leading South African law firm Webber Wentzel.

We are advising a significant shareholder of a Jersey Collective Investment Fund in relation to possible claims that might exist against the Manager and/or former directors of the Fund arising from the Fund's poor performance. Any claim would be significant; this is potentially high value and complex litigation. Pursuant to a Chinese Wall arrangement we have also recently been instructed by the Fund itself to provide corporate and other advice.

A groundbreaking platform fund structure developed by Collas Crill and one of Jersey's leading fund administrators.  The platform provides for the cost effective formation (approximately 70% cost saving) of independent funds with different investment managers, each of which is advised as to Jersey legal matters by Collas Crill and regulated as an expert fund by the Jersey Financial Services Commission.

Acted with Simmons & Simmons on the migration of a Cayman master/feeder structure to Guernsey as a class B collective investment scheme.  The structure was migrated to Guernsey to meet the requirements of key existing and potential investors and to align the fund with the domicile of the manager. This is the second GoldenPeaks fund the firm worked on.  Also acted in 2007/8 to migrate the manager from the Caymans to Guernsey.

Acted for the Gateway Fund (which migrated to Guernsey in 2009/10) in relation to the proposed registration of the fund with the Swiss Regulator (FINMA) to permit retail sales in Switzerland.

Acted for Northern Trust (Guernsey) Limited in respect of a US$250,000,000 facility being made available to a suite of funds domiciled in Guernsey and the British Virgin Islands.  Due to the custody structure used, this involved complex Guernsey Law security arrangements for all funds and liaison with English, Irish and BVI Counsel.

Acted for Innovatis Guernsey Limited in connection with the listing on the Channel Islands Stock Exchange LBG of shares issued by the OFX Strategy Fund, a cell of Innovatis PCC Limited. The OFX Strategy Fund's strategy is to achieve substantial capital appreciation over the medium term by holding and selling Bonds, Zero-Bonds, Medium Term Notes, Structured Notes, Promissory Notes, Letters of Credit, Bank Guarantees, Certificate of Deposit, Money Market Instruments issued and/or sold by banks and companies around the world provided that they are rated investment grade or better by at least one of the major rating agencies.

Acted for Smith & Williamson Limited in respect of their role as administrator of the KCP II Fund. Matter involved review of the constitution of the limited partnership and the appointment of the administrator and providing an opinion in respect of the proposed steps to be taken by the administrator to sell certain assets of the fund.

Acted for Meteor Asset Management Limited to launch an innovative bond fund as a Q-scheme.  Q-schemes are a rarity in recent times for Guernsey, but the unique offering lent itself well to the flexible regime.  The strategy involving 24 cells of the PCC ranges from very short term to longer term investments in the bond market, focusing primarily on matched tracks to maximise returns.

Advised on the establishment and regulation of a bespoke closed ended limited partnership to be regulated as an Expert Fund and launched early 2011. The Expert Fund value is more than US$14 million.